News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘Leukemia’ clear

  • Studies in zebrafish show that a 50-year-old antipsychotic medication can actively combat the cells of a difficult-to-treat form of acute lymphoblastic leukemia (ALL).

Tags: Leukemia

  • When Charlie was diagnosed with acute lymphoblastic leukemia at age 4, his mother sent regular email updates to her large family and circle of friends. Her reflections grew into a touching chronicle of four years in the life of a child with cancer.

Tags: ChildhoodCancer, StemCellTransplant, PatientVideos, Leukemia

  • Tens of thousands of childhood cancer survivors are now in their 20s, 30s, and beyond, facing life-long risks of treatment-related health issues. Increasingly, primary care physicians will need to be knowledgeable about symptoms and complaints that might be related to cancer treatments their patients received decades ago.

Tags: ChildhoodCancer, Survivorship, Leukemia

  • Prophylactic antibiotics significantly reduce the risk of serious bacterial infections in children during the critical first month of treatment for acute lymphoblastic leukemia (ALL), the most common childhood cancer, according to investigators from Dana-Farber/Boston Children's Cancer and Blood Disorders Center. While the overall cure rate for ALL is high, about one to two percent of children die during the first month of therapy from treatment complications, primarily infection-related.

Tags: ChildhoodCancer, Leukemia

  • Results suggest kinase inhibitor, teamed with chemotherapy, might reduce the need for donor stem cell transplantation in some AML patients.

Tags: KinaseInhibitor, Leukemia

  • Common variations in four genes related to brain inflammation or cells' response to damage from oxidation may contribute to the problems with memory, learning and other cognitive functions seen in children treated for acute lymphoblastic leukemia (ALL), according to research presented at the annual American Society of Hematology annual meeting in San Francisco.

Tags: ChildhoodCancer, Survivorship, Leukemia

  • A team of researchers led by Dana-Farber Cancer Institute investigators has uncovered a connection between people with Down syndrome and having a heightened risk of developing acute lymphoblastic leukemia (ALL) during childhood.

Tags: BasicResearch, Leukemia

  • Dana-Farber scientists report that midostaurin added to standard chemotherapy is the first targeted treatment to improve survival of a high-risk, genetically defined subgroup of patients with acute myeloid leukemia.

Tags: TargetedTherapy, Leukemia

  • Dana-Farber researchers found that an experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen of care, but that the new combination could provide an alternative that could be preferable in certain scenarios.

Tags: GraftVersusHost, StemCellTransplant, Leukemia

  • A study led by Dana-Farber investigators found that a phase 1 trial of an immune checkpoint blocker found clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation.

Tags: MultipleMyeloma, Leukemia, Immunotherapy

Showing 1-10 of 36 items